Stay updated on Vorinostat and Azacitidine in MDS/AML Clinical Trial
Sign up to get notified when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.

Latest updates to the Vorinostat and Azacitidine in MDS/AML Clinical Trial page
- Check4 days agoChange DetectedSeveral new history entries were added, including updates to Study Status across recent versions (from 2026-02-14 to 2026-02-20). This expands the recorded history of the study's status changes.SummaryDifference0.6%

- Check11 days agoChange DetectedThe page history was updated with a new revision (v3.4.2 on 2026-02-12) and removal of an older revision (v3.4.1), affecting only revision metadata. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check19 days agoChange DetectedThe page footer now shows a revision update from v3.4.0 to v3.4.1, indicating a small site update. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check26 days agoChange DetectedUI and metadata changes include a glossary toggle, color-coded add/delete highlights in the history, and updated revision information.SummaryDifference0.4%

- Check42 days agoChange DetectedRevision history shows an added v3.3.4 entry and a removed v3.3.3 entry, reflecting a site version update without altering study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded 'Revision: v3.3.3' to the page footer. Removed 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' from the footer.SummaryDifference0.1%

Stay in the know with updates to Vorinostat and Azacitidine in MDS/AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Vorinostat and Azacitidine in MDS/AML Clinical Trial page.